Trial Profile
A phase IV, open-label, multi-center trial to evaluate the safety and efficacy of Keppra after conversion to mono-therapy in adult subjects with partial epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2009
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors UCB
- 28 Mar 2008 New trial record.